These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Administrative detention of food for human or animal consumption under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002. Final rule. Food and Drug Administration, HHS. Fed Regist; 2004 Jun 04; 69(108):31659-705. PubMed ID: 15181899 [Abstract] [Full Text] [Related]
6. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment. Roller ST, Pippins RR, Ngai JW. Food Drug Law J; 2009 Jun 04; 64(3):577-98. PubMed ID: 19999646 [Abstract] [Full Text] [Related]
7. Establishment, maintenance, and availability of records: amendment to record availability requirements. Final rule. Food and Drug Administration, HHS. Fed Regist; 2014 Apr 04; 79(65):18799-802. PubMed ID: 24716304 [Abstract] [Full Text] [Related]
8. Title III of the Bioterrorism Act: sacrificing U.S. trade relations in the name of food security. Boisen CS. Am Univ Law Rev; 2007 Jan 04; 56(3):667-718. PubMed ID: 17312612 [No Abstract] [Full Text] [Related]
9. Prevention of Salmonella enteritidis in shell eggs during production, storage, and transportation. Final rule. Food and Drug Administration, HHS. Fed Regist; 2009 Jul 09; 74(130):33029-101. PubMed ID: 19588581 [Abstract] [Full Text] [Related]
10. Possession, use, and transfer of select agents and toxins. Final rule. Centers for Disease Control and Prevention, Office of Inspector General, Department of Health and Human Services (HHS). Fed Regist; 2005 Mar 18; 70(52):13293-325. PubMed ID: 15776528 [Abstract] [Full Text] [Related]
11. How the FDA food safety modernization act responds to terrorism threats: a primer. Woodlee JW. Biosecur Bioterror; 2012 Sep 18; 10(3):258-62. PubMed ID: 22835056 [No Abstract] [Full Text] [Related]
13. Current good manufacturing practice in manufacturing, packaging, labeling, or holding operations for dietary supplements. Final rule. Food and Drug Administration, HHS. Fed Regist; 2007 Jun 25; 72(121):34751-958. PubMed ID: 17674484 [Abstract] [Full Text] [Related]
14. FDA regulation of dietary supplements and requirements regarding adverse event reporting. Frankos VH, Street DA, O'Neill RK. Clin Pharmacol Ther; 2010 Feb 25; 87(2):239-44. PubMed ID: 20032973 [Abstract] [Full Text] [Related]
15. Medical devices; medical device reporting. Direct final rule. Food and Drug Administration, HHS. Fed Regist; 2005 Feb 28; 70(38):9516-28. PubMed ID: 15736310 [Abstract] [Full Text] [Related]
19. Current good manufacturing practices, quality control procedures, quality factors, notification requirements, and records and reports, for infant formula. Final rule. Food and Drug Administration, HHS. Fed Regist; 2014 Jun 10; 79(111):33057-72. PubMed ID: 24922980 [Abstract] [Full Text] [Related]